Gem Aromatics IPO Opens Today, 19 August: Everything You Need to Know About Price, GMP & Listing

Gem Aromatics IPO has finally opened for subscription today, August 19th, and will close on August 21st. Operating in the aroma chemicals and fragrance sector, Gem Aromatics is being closely watched because of its high demand in the grey market. Since this is a growing market segment, the IPO is expected to give potential for early returns to investors.

Gem Aromatics IPO Size and Structure

The Gem Aromatics IPO is worth Rs. 451.25 crore. The issue is split into a fresh issue of 0.54 crore shares valued at Rs. 175 crore and an offer for sale of 0.85 crore shares totalling Rs. 276.25 crore. The fresh issue proceeds will support business expansion, while the OFS allows existing shareholders to partially monetise their holdings.

Gem Aromatics IPO Price Band and Lot Size

The IPO comes with a price band of Rs. 309 to Rs. 325 per share and a lot size of 46 shares per application. At the upper price band, the market capitalisation of Gem Aromatics is estimated at approximately Rs. 1,697.71 crore.
The IPO is managed by Motilal Oswal Investment Advisors Ltd, the Book Running Lead Manager (BRLM), and Kfin Technologies Ltd is the registrar for the issue.

Gem Aromatics IPO GMP and Expected Listing Price

The grey market premium is a key indicator of market sentiment before the IPO listing. Ahead of the opening of the subscription window, the GMP for Gem Aromatics stood at Rs. 21 per share as of August 18, 2025, 5:33 PM.Based on the cap price of Rs. 325, the expected listing price is around Rs. 346 per share, with a potential listing gain of 6.46%.

Should You Invest in the Gem Aromatics IPO?

Gem Aromatics IPO offers an attractive opportunity to enter the aroma chemicals sector, which has shown steady growth. SBI Securities has given a subscribe rating to the IPO, citing the improved financials of the company.

"The company has grown at a decent rate over FY23-25 with Revenue/EBITDA/PAT.CAGR of 8.9%/15.6%/9.3%, respectively. EBITDA margin has improved ~200 bps. during this period. Total capacity of GAL has grown at a 12.5% CAGR between FY23- 25. The company is enhancing its manufacturing capacity in Dahej while also widening its product portfolio (new product category citral with products including safranal and damascene), which will aid in deriving sustainable growth. At the upper price band of Rs 325, GAL is valued at a post-issue capital FY25 PE of 31.8x, which looks more attractive than its peers. We recommend investors SUBSCRIBE to the issue at the cut-off price for the long term," the SBI Securities IPO note stated.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.